Dr. Vozoris found the increases in co-usage very concerning given that these drug-use patterns are associated with increased risks for serious adverse outcomes including breathing problems and death.
"While the proportions may seem small, these percentages at a population-level correspond to millions of people and the growth of these numbers is alarming," said Dr. Vozoris, a sleep medicine doctor who often sees patients in his clinic who are taking a worrisome or dangerous combination of drugs.
"The FDA has gone as far as to issue its strongest form of safety warning about this suboptimal prescribing practice and mixing of opioids and benzodiazepines."
The 1.36 percent prevalence of benzodiazepine and opioid co-usage translated to about 4.3 million people, while the 0.47 percent prevalence of benzodiazepine and Z-drug co-usage amounted to about 1.5 million people.
Dr. Vozoris said he's seen a lot of confusion about benzodiazepines and Z-drugs among both patients and other medical professionals.
Commonly prescribed benzodiazepines include alprazolam, clonazepam and lorazepam while Z-drugs include zaleplon, zolpidem and zopiclone.
"There are doctors and members of the public often not realizing that Z-drugs are very similar in action to benzodiazepine drugs -- sometimes patients get put on both a benzo and a Z-drug and think they're two very different drugs," Dr. Vozoris said.
"I wanted to understand the trends in use of such worrisome drug combinations and which types of individuals were more likely to receive such drug combinations."
Source: Eurekalert
